Catalepsy Treatment Market Industry Outlook, Opportunities in Market And Expansion By 2033Posted by ramacharitbrc on May 28th, 2024 ![]() Overview and Scope Catalepsy treatment refers to a procedure that focuses on reducing the symptoms of catalepsy such as loss of voluntary motion, fixed posture, and decreased sensitivity to pain by using medication and muscle relaxants. They are used for reducing muscle rigidity. The catalepsy treatment market size has grown strongly in recent years. It will grow from .96 billion in 2023 to .51 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to economic factors, awareness and education, healthcare infrastructure development, drug approvals and regulatory landscape, advancements in medical research. https://www.thebusinessresearchcompany.com/report/catalepsy-treatment-global-market-report The catalepsy treatment market covered in this report is segmented – 2) By Route of Administration: Oral, Parenteral, Other Routes 3) By End User: Hospitals, Specialty Clinics, Other Users https://www.thebusinessresearchcompany.com/sample.aspx?id=9431&type=smp The growing prevalence of chronic diseases is expected to propel the catalepsy treatment market going forward. Chronic conditions are illnesses or conditions that typically endure for three months or longer and may deteriorate over time. The majority of chronic diseases can be managed but not cured, and they typically affect older persons. The prevalence of catalepsy is rising along with other toxic or infectious diseases linked to chronic illnesses, requiring catalepsy treatment. For instance, in September 2022, according to the World Health Organization, a US-based specialized agency responsible for international public health, about 41 million people will die each year, which is equivalent to 74% of all deaths globally, because of chronic noncommunicable diseases (NCD). Further, all the NCD deaths will be around 77% in low- and middle-income countries. Therefore, the growing prevalence of chronic diseases is driving the catalepsy treatment market. Major companies operating in the catalepsy treatment market are focusing on innovative products such as baclofen oral granules to drive revenues in their market. Baclofen oral granules refer to a form of the medication baclofen that comes in granular or powder form, designed to be taken orally. For instance, in June 2022, Amneal Pharmaceuticals, Inc. a US-based pharmaceutical company launched lyvispah. Lyvispah works on spinal cord nerves to lessen the frequency and intensity of muscular spasms in people with specific spinal cord-related disorders. This is a strawberry-flavored, dissolvable granular formulation of baclofen that comes in packets containing 5 mg, 10 mg, and 20 mg. It can be purchased through specialist and retail channels. 2. Market Characteristics 3. Market Trends And Strategies 4. Impact Of COVID-19 5. Market Size And Growth 6. Segmentation 7. Regional And Country Analysis ……… 27. Competitive Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis Like it? Share it!More by this author |